These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7421560)

  • 21. [Drug therapy of coronary heart disease with nitrisken retard].
    Kugler G; Welzel D; Schiess W
    Ther Ggw; 1982 Mar; 121(3):172-87. PubMed ID: 7046127
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
    Parker JO; Baird MG
    Can J Cardiol; 1994 Nov; 10(9):909-12. PubMed ID: 7954026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bioavailability of 2 different depot formulations with 40 mg of isosorbide dinitrate].
    Segre G; Zanolo G; Mondino A; Giachetti C; Silvestri S
    Fortschr Med; 1981 Dec; 99(47-48):2008-13. PubMed ID: 7327496
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dynamic ECG evaluation of the activity of long-acting isosorbide dinitrate in patients with unstable angina (author's transl)].
    Pedone V; Bellotti L; Belluzzi D; Di Biase G
    G Ital Cardiol; 1981; 11(10):1450-5. PubMed ID: 7042436
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of slow nitrate by products in heart patients at rest and during cyclo-ergometric tests (author's transl)].
    Boutefeu JM; Righetti A; Rutishauser W
    Ann Cardiol Angeiol (Paris); 1979; 28(2):129-34. PubMed ID: 378089
    [No Abstract]   [Full Text] [Related]  

  • 26. [The clinical evaluation of the efficacy of Isoket in patients with vasospastic stenocardia].
    Bobrov VA; Simorot VN
    Ter Arkh; 1992; 64(9):39-42. PubMed ID: 1481153
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ergometric study of the duration of action of a delayed-action trinitrine in angina pectoris patients].
    Biour M; Yvenou L; Khireddine M; Gluck C; Parier JL; Cheymol G
    Therapie; 1988; 43(1):45-9. PubMed ID: 3128886
    [No Abstract]   [Full Text] [Related]  

  • 28. [Long-term study with Stenoptin in general practice].
    Kessler H
    Med Welt; 1980 Jan; 31(4):149-51. PubMed ID: 6154224
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effectiveness of isosorbide dinitrate and pentaerythritol tetranitrate by means of acute determination of the coronary reserve on cycloergometer in patients with stable angina pectoris].
    Poprawski K
    Pol Arch Med Wewn; 1979 Sep; 62(3):221-9. PubMed ID: 523326
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of sorbonite on exercise tolerance in stable angina pectoris].
    Juszczyk Z
    Pol Tyg Lek; 1982 May; 37(11):301-4. PubMed ID: 7122293
    [No Abstract]   [Full Text] [Related]  

  • 31. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of isosorbide dinitrate and nitroglycerin in patients with angina pectoris].
    Zikmund M; Mayer O; Cepelák V
    Vnitr Lek; 1984 Nov; 30(11):1060-5. PubMed ID: 6440352
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
    Kośmicki M; Sadowski Z
    Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of 50 mg isosorbide-5-nitrate retard on the stress tolerance of patients with coronary heart disease].
    Eggeling T; Jansen W; Osterspey A; Tauchert M; Hilger HH
    Med Klin (Munich); 1986 Apr; 81(8):275-80. PubMed ID: 3785087
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of simultaneous episodes of angina and respiration disorders].
    Lazebnik LB; Lesnia EA; Tereshchenko SN
    Klin Med (Mosk); 1993; 71(5):27-9. PubMed ID: 8301979
    [No Abstract]   [Full Text] [Related]  

  • 36. [Approaches to the personal antianginal therapy. Can we consider nitrosorbide as a drug of choice?].
    Zhiliaev EV; Glazunov AV; Koroba GS
    Klin Med (Mosk); 1994; 72(4):62-4. PubMed ID: 7990387
    [No Abstract]   [Full Text] [Related]  

  • 37. [Value of Iso Mack Retard in the treatment of coronary disease].
    Zminkowska U; Markiewicz M
    Wiad Lek; 1984 Apr; 37(7):496-500. PubMed ID: 6385487
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease.
    Hung MJ; Cherng WJ; Cheng CW; Yang NI
    Am J Cardiol; 2005 Jan; 95(1):84-7. PubMed ID: 15619396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antianginal effect of transdermal isosorbide dinitrate (multicenter study)].
    Kékes E
    Orv Hetil; 1994 Oct; 135(44):2421-3. PubMed ID: 7970662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of coronary insufficiency with a combination of 2 nitro-derivatives. Controlled pluricentric clinical trial].
    Di Prisco AU; Vaccari GL; Soro A; Mora A
    Minerva Med; 1975 Feb; 66(12):551-61. PubMed ID: 1113905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.